The foremost gathering of CEOs of international and local pharmaceutical producers, distributors and retailers

14 - 15 May 2019

Corinthia Saint-Petersburg Hotel

Lead Partner

Back to sponsors page
Pharmasyntez

M&A Partner

Back to sponsors page
Novus Capital

Sponsors

Back to sponsors page
DSM
Back to sponsors page
IQVIA
Back to sponsors page
AlphaRM
Back to sponsors page
Sensitech
Back to sponsors page
STEM
Back to sponsors page
Proxima Research
Back to sponsors page
Veeva Systems
Back to sponsors page
PwC
Back to sponsors page
Baker McKenzie
Back to sponsors page
BREFFI
Back to sponsors page
MFO
Back to sponsors page
Bilfinger
Back to sponsors page
Doktor na rabote
Back to sponsors page
Aaron Lloyd
Back to sponsors page
Rx Code
Back to sponsors page
ACG
Back to sponsors page
IPSOS

Supporting Organisations

Back to sponsors page
-
Back to sponsors page
-

Information Partners

Back to sponsors page
PharmVestnik
Back to sponsors page
-
Back to sponsors page
GMP News
Back to sponsors page
-
Back to sponsors page
-
Back to sponsors page
MediaMedica
Back to sponsors page
-
Back to sponsors page
Interfax

JSC Pharmasyntez has been in the pharmaceutical market since 1997. The company is focused on development and production of pharmaceutical products for the treatment of socially significant diseases, such as TB, HIV/AIDS, hepatitis, oncological and blood diseases. The company is one of the largest manufacturers of antibiotics in Russia.

The company's mission is
• to produce effective drugs of high quality demanded by the modern medicine;
• to develop innovative pharma products;
• to increase the share of domestic drugs on the Russian market by substitution of imported analogues.
Pharmasyntez group structure:
• Irkutsk facility – JSC Pharmasyntez
• Ussuriysk facility – LLC EAST-PHARM
• Tyumen facility – LLC Pharmasyntez-Tyumen
• Bratsk facility – LLC BratskChemSyntez
• Saint Petersburg facility – JSC Pharmasyntez-Nord
Pharmasyntez is one of the top 10 leading pharmaceutical companies in Russia in terms of production growth and one of the top 3 fast-developing pharmaceutical enterprises on the Russian market.
The output of the Pharmasyntez group is 50 million packs per year
Its annual turnover: more than 10 billion rubles
Company's staff: 1500 highly skilled specialists
Three plants of the Pharmasyntez group in Irkutsk, Ussuriysk, and Tyumen are now producing 113 pharmaceutical products of different dosage forms and strengths: capsules, tablets, granules, infusion solutions, sterile dry powders and solutions for injection.

Investment activity:
A research and production complex for development and manufacture of anticancer and biotech drugs is being constructed in St. Petersburg; the 1st stage of construction is ongoing now; it is scheduled for commissioning in 2018.
In Bratsk, the construction of a plant for manufacturing of active pharmaceutical ingredients is about to be completed, the full cycle production is scheduled for 2017, this will allow to provide a full cycle production of the company’s drugs.
To implement these plans, Pharmasyntez invests more than 5 billion rubles in development of its own production facilities.

R&D:
Development of innovative pharma products and their introduction into a manufacturing process is a priority of the company. Annually, the Company invests up to 500 mln. rubles in scientific researches. The company is continuously working towards finding New Molecular Entities for combating TB, HIV, and other diseases.
Annually, the Company synthesizes 300 to 500 new molecules.
Several years ago, a New Chemical Entity was developed for the treatment of multi-drug resistant tuberculosis (MDR-TB), and in 2015 it was listed as a VEN drug.
The phase II clinical trial of a radically new, first-of-its class pharmaceutical product for the prevention of adhesive disease is ongoing now.

Visit our website

Novus Capital is a leading regional investment banking firm in pharmaceutical industry with geographic focus on Russia, the CIS and the Baltic States. Novus Capital professionals have a broad experience in advising owners and foreign investors in M&A transactions and related activities (due diligence, structuring, negotiations etc.). In recent years our team executed a number of cross border transactions in pharmaceutical industry with total value of USD 450 m, making our team the leading financial adviser to pharmaceutical companies in Russia.

Visit our website

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of human data science a reality. IQVIA’s approach to human data science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, advanced technology and analytics with extensive industry knowledge.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing the information that helps their customers drive human health outcomes forward. IQVIA’s insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.IQVIA.com.

 

Visit our website

AlphamRM analytical company covers the full range of analytical and marketing services in the pharmaceutical sector.
Our services comprise:
Audit of retail sales of medical products (sell out)
Audit of medical products purchases by pharmacy chains (sell in)
Geomarketing of pharmacy chains
Audit of medical products shipments to pharmacies to treatment-and preventive care establishments
Audit of the federal segment of medical products concessional provision
Audit of the regional segment of medical products concessional provision
Certification of pharmacy segment
Governmental procurement monitoring
Audit of target segment of medical product delivery

Visit our website

Sensitech is focused on delivering supply chain visibility solutions that track, monitor and protect products for global leaders in the food, life sciences, consumer goods, and industrial markets. Our solutions are focused in three key areas: quality and compliance, supply chain security, and logistics performance management. Quality and compliance solutions address temperature-sensitive, complex supply chains focused on delivering the highest quality possible, while our supply chain security solutions help to mitigate risks associated with theft, diversion and chain of custody. Sensitech’s logistics performance solutions deliver origin-to-destination, real-time transparency to any in-transit journey.

Visit our website

STEM is the global benchmarking company that partners with 29 of the top 30 pharmaceutical companies to further accelerate performance. We work with commercial, field medical, field access and account management teams. Our benchmark database is the biggest in the industry, built on >300,000 in-field observations. We partner with your Brand Team, to identify practical evidence-based recommendations.

The STEM vision is to be in every brand plan, working to highly professional core values.

We are based in seven offices globally, a presence in >40 countries, and experience in all therapy areas.

STEM received the prestigious Queen’s Award for Enterprise, recognising the contribution to international trade, in 2016.

For further information visit our website at www.stemhealthcare.com

Visit our website

Proxima Research LLC is part of an international group of companies, which includes key solution-vendors for the life-science industry in CIS countries, covering the complete scope of pharmaceutical companies’ needs in IT-solutions, data for decision-making and product promotion for the last 15 years. Proxima Research LLC provides expert solutions in the area of CRM/ETMS integration and support, HCP/HCO database management, multichannel marketing, BI-solution’s implementation, IT-development, market data, marketing research and consulting.

Visit our website

Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 275 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.eu.veeva.com

Visit our website

PwC Russia (www.pwc.ru) provides industry-focused assurance, tax, legal and advisory services. Over 2,500 professionals working in PwC offices in Moscow, St Petersburg, Ekaterinburg, Kazan, Rostov-on-Don, Krasnodar, Voronezh, Novosibirsk, Vladikavkaz and Ufa share their thinking, experience and solutions to develop fresh perspectives and practical advice for our clients.
PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity.
Together, these firms form the PwC network, which includes over 236,000 employees in 158 countries. Please see http://www.pwc.ru/ru/about.html for further details.

Visit our website

For more than 65 years Baker McKenzie has been effectively providing global advice in the pharmaceutical sector, and for over 25 of those years providing such advice here in the CIS. The size and global reach of our Firm, with its 77 offices in 47 countries, guarantee that know-how is shared among jurisdictions and allow resources from our international network to supplement local office needs. Having assisted in the foundation of the Association of International Pharmaceutical Manufacturers and the International Medical Devices Manufacturers Association, we advise clients on the full spectrum of legal concerns in the CIS, including customs and trade regulation, as well as WTO and EurAsEC-consistent policy. (www.bakermckenzie.com)

Visit our website

The communication group «Aaron Lloyd» is a media agency, working in the pharmaceutical market since 1999.
We have a lot of expert employees, including a Medical director, who provide additional support to our clients in relation to marketing.
We are involved in strategic and tactical media-planning, econometric modelling and implement unusual projects and 360° campaigns. We also provide educational programs for our Clients.
«Aaron Lloyd» agency is the only subscriber for industrial data from QuintilesIMS and Alpharm.
From 2014 the agency has been a strategic partner of Dentsu Aegis Network group in Russia.
From 2016 a special medical program «Agents 003» is broadcast on TNT channel with involvement of the Agency «Aaron Lloyd».

Visit our website

The marketing agency RX Code is one of the leaders in the Russian market of pharmaceutical products and medical equipment promotion.
The company is an expert in the provision of services for personnel outsourcing, remote communication with doctors and pharmacies, organization of training courses and special social projects, as well as in creative solutions for all types of media.

Visit our website

ACG is a leading Track and Trace solution provider for serialization of cartons and bottles at primary, secondary, and tertiary levels of packaging for regulated markets. Our advanced solutions support majority of product configuration under the serialization mandate. The variety of product lines can cater to all available line level configurations in pharmaceutical plants. We work closely with pharmaceutical companies across the globe as a track and trace implementation partner. We help at every stage - from complete project planning and implementation to process.
ACG’s machines and application integration capabilities with strong service support enable us to cater to every serialization requirement. Our robust solutions can tackle implementation and interoperability challenges faced at level 1 to level 5 in the end-to-end supply chain.

Visit our website

Ipsos Healthcare Russia as a part of the Global Ipsos Healthcare specializes on Russian Healthcare market for over past two decades and working with the most of market players and their HQs.
Deep understanding of the Russian healthcare and pharmaceutical market coupled with a wide range of analytical services and modern research tools allows us to keep a leading position in this segment.
Almost 50 employees Ipsos Healthcare (Russia) focusing exclusively on Healthcare research and offering a full range of services in the following areas: Syndicated research, Custom research (AdHoc), Analytics and consultancy and Educational trainings.
Our Syndicated Surveys cover over 15 000 physicians and more than 4 500 pharmacists annually providing our clients with actual and precise data on the Russian pharmaceutical market.
Custom research both for Qualitative and Quantitative parts and also supporting by our Analytics&Consultancy service allows our clients to update regularly market feedback on various segments.
Educational project School of Pharmaceutical Marketing within last 9 years offers a wide range of educational workshop and training programs conducted by leading trainers and market experts.

Visit our website

Established in 1994. The Association comprises 60 international pharmaceutical companies that provide over 80% of the world’s pharmaceutical products and over 60% of medicines imported to the Russian Federation.

AIPM Mission

To promote economic and legal policies that focus on the development of organized and open pharmaceutical market, improving of medical services quality and expansion of the range of modern medicines for the benefit of Russian people.

Visit our website

http://www.en.arfp.ru/

Visit our website

http://spfo.ru/

Visit our website

http://sojuzpharma.ru/

Visit our website

http://pharmjournal.ru/

Visit our website

http://vrachivmeste.ru/

Visit our website

http://gmpnews.ru/

Visit our website

http://promoboz.com

Visit our website

www.medbusiness.ru

Visit our website

http://www.con-med.ru/

Visit our website

http://www.farmsouz.ru/

Visit our website

Interfax is the biggest information group in the CIS and the recognized leader in the B2B segment of Russia’s information market.

Interfax is the most frequently cited source for information on Russia and the CIS in the foreign press.

Interfax develops professional information solutions that help companies operate in the financial and commodity markets, enabling them to reach investment decisions, manage risk, organize external communications and fulfill regulatory requirements.

Visit our website